By 2024 Latin America Molecular Diagnostics Market Size to Grow at Valuation of USD 950 Mn

Graphical Research has reported the addition of the “Molecular Diagnostics Market: Latin America Industry Analysis and Opportunity Assessment 2019 - 2024" report to their offering.

India - August 14, 2019 /MarketersMedia/ —

Growing awareness about early disease diagnosis and prevention has stimulated demand for molecular diagnostics in detection of cancer and infectious disease at early stage. Molecular diagnostics has become an integral part of disease management owing to its wide applications in drug regimen selection, therapeutic monitoring, patient stratification and detection of predisposition to disease. High accuracy level coupled with reliability and efficacy will further surge the demand for molecular diagnostics thereby boosting Latin America molecular diagnostics business growth.

Request for a sample of this report @ https://www.graphicalresearch.com/request/1174/sample

According to the Graphical Research new growth forecast report titled Latin America Molecular Diagnostics Market Size By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In Situ Hybridization, Chips & Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification), Industry Analysis Report, Country Outlook (Brazil, Mexico, Argentina, Colombia, Chile, Peru), 2018 – 2024”, estimated to exceed USD 950 million by 2024.

Furthermore, technological advancement in molecular diagnostics will serve to be positive impact rendering factor in business growth. Availability of small handheld portable POCT devices used by healthcare professionals or patients will escalate the demand for point of care diagnostics. Rising incidence of lifestyle diseases such as diabetes, growing investment in R&D to develop cost effective and user-friendly POCT devices and increasing focus of industry players on new product development will stimulate molecular diagnostics market growth. However, lack of uniform regulatory framework may impede Latin America molecular diagnostics industry growth over the coming years.

Infectious disease segment accounted for more than USD 220 million in 2017 and is projected to show similar growth over the coming years. Prevalence of infectious diseases such as flu, tuberculosis, meningitis, STD, HIV, hepatitis C, hepatitis B, dengue and others is increasing in recent years. Rising awareness about early disease diagnosis and timely treatment will spur the demand for molecular diagnostics. Availability of rapid molecular tests delivering results in few hours will increase its adoption in detection of infectious disease and will fuel segmental growth during forthcoming years.

Make an Inquiry for purchasing this Report @ https://www.graphicalresearch.com/request/1174/inquiry-before-buying

PCR segment held significant revenue share in 2017 and is expected to witness around 8.5% CAGR over the forecast period. Technological advancements in PCR including target specific PCR allowing amplification and simultaneous detection of pathogen DNA will drive business growth. Increasing usage of PCR in medical industry and diagnostic laboratories will spur segment revenue. Moreover, application of PCR in molecular diagnostics for monitoring of chronic osteomyelitis ensures accurate results. Thus aforementioned factors will foster PCR segmental growth over the analysis timeframe.

Brazil molecular diagnostics market is estimated to witness more than USD 385 million by 2024. Growing demand for robust, rapid and reproducible diagnosis of infectious diseases for better control of mortality and morbidity will positively impact Brazil molecular diagnostics business growth over the forecast period. Focus of industry players on development and distribution of affordable devices resulting in increased use of molecular diagnosis tests will propel business size. Increasing demand for cost-effective diagnosis and advanced technologies for better patient outcomes will accelerate industry growth.

Browse Table of Contents @ https://www.graphicalresearch.com/table-of-content/1174/latin-america-molecular-diagnostics-market

Few prominent players operating in Latin America molecular diagnostics market include Abbott, Agilent, Analytik Jena, Becton, Dickinson & Company, Biocartis, BioFire Diagnostics, BioMérieux, Bio-Rad Laboratories, Danaher and Genomic Health. Industry players are undertaking numerous initiatives to gain higher market share and strengthen market position. For instance, in May 2017, company launched Alere Malaria Ag P.f assay for asymptomatic malaria infection. This strategy enabled company to enhance its existing product portfolio and capitalize on market opportunities.

Segments we cover:

Latin America Molecular Diagnostics Market, By Application

Infectious disease
Flu
RSV virus
Tuberculosis
Meningitis
HIV market
Hepatitis C
Hepatitis B
HPV
STD
Chlamydia
Gonorrhea
Others
Dengue
H. Pylori
TORCH
Others
Blood screening
Genetic testing
Oncology testing

Latin America Molecular Diagnostics Market, By Technology

PCR
In situ hybridization
Chips & microarrays
Mass spectrometry
Sequencing
Isothermal amplification
Others

Browse key industry insights from this Report @ https://www.graphicalresearch.com/industry-insights/1174/latin-america-molecular-diagnostics-market

Contact Info:
Name: Parikhit B.
Email: Send Email
Organization: Graphical Research
Website: https://www.graphicalresearch.com/industry-insights/1174/latin-america-molecular-diagnostics-market

Source URL: https://marketersmedia.com/by-2024-latin-america-molecular-diagnostics-market-size-to-grow-at-valuation-of-usd-950-mn/88908156

Source: MarketersMedia

Release ID: 88908156

Latest News

With eyes on election, White House insists economy is strong

Aug 20, 2019

WASHINGTON — The "fundamentals" of the U.S. economy are solid, the White House asserted on Monday, invoking an ill-fated political declaration of a decade ago amid mounting concern that a recession could imperil President Donald Trump's reelection. Exhibiting no such concern, senior adviser Kellyanne Conway declared to reporters, "The fact is, the fundamentals of our economy are very strong," It's a phrase with a history. Republican John McCain was accused of being out of touch when he made a similar declaration during the 2008 presidential campaign just hours before investment bank Lehman Brothers filed for bankruptcy, setting off a stock...

74% of economists in survey see US recession by end of 2021

Aug 20, 2019

WASHINGTON — A strong majority, 74%, of U.S. business economists appear sufficiently concerned about the risks of some of President Donald Trump's economic policies that they expect a recession in the U.S. by the end of 2021. The economists surveyed by the National Association for Business Economics, in a report released Monday, mostly didn't share Trump's optimistic outlook for the economy, though they generally saw recession coming later than they did in a survey taken in February. Thirty-four percent of the economists surveyed said they believe a slowing economy will tip into recession in 2021. That's up from 25% in...

Asian shares rise as investors watch trade war, economies

Aug 20, 2019

TOKYO — Asian shares were higher Monday, as investors continue to rejigger their read on President Donald Trump's trade war and growing worries about slowing economies around the world. Japan's benchmark Nikkei 225 rose 0.6% in early trading to 20,532.95. Australia's S&P/ASX 200 gained 0.8% to 6,454.40, while South Korea's Kospi was 0.4% higher at 1,934.78. Hong Kong's Hang Seng rose 0.9% to 25,734.22. The Shanghai Composite added 0.3% to 2,823.82. On Friday, the S&P 500 rose 41.08 points, or 1.4%, to 2,888.68. The Dow, which had an 800-point drop earlier in the week, added 306.62 points, or 1.2%, to...

Japan's exports fell in July for 8th straight month

Aug 20, 2019

TOKYO — Japan's exports fell for the eighth straight month in July as worries continued about President Donald Trump's trade policies denting Asian economic growth. Ministry of Finance data released Monday showed exports and imports fell in July, compared to the same month a year ago. Exports fell 1.6%, while imports slid 1.2%, resulting in a trade deficit of 249.6 billion yen ($2.35 billion). Global markets have been in turmoil because of Trump's trade war with China. A slowdown in China is certain to hurt other regional economies, including Japan's. Japan's exports to China in July fell 9.3% while its...

Trump wields sanctions hammer; experts wonder to what end

Aug 20, 2019

WASHINGTON — Call it the diplomacy of coercion. The Trump administration is aggressively pursuing economic sanctions as a primary foreign policy tool to an extent unseen in decades, or perhaps ever. Many are questioning the results even as officials insist the penalties are achieving their aims. Since taking office in January 2017, President Donald Trump has used an array of new and existing sanctions against Iran, North Korea and others. His Treasury Department, which oversees economic sanctions, has targeted thousands of entities with asset freezes and business bans. The State Department has been similarly enthusiastic about imposing its own penalties:...

Search

Obserworld delivers the most accurate and up-to-date world news for the global audience with a thorough research and in-depth interviews. Discover the world through Obserworld.

Contact us: sales[at]obserworld.com